New Chemo, New Hope

In a battle of war, if the enemy decoded our secret weapons, what do we do?  We use newer and more powerful weapons to destroy the enemy!  The June PET scan result shows that Gwohann's cancer is growing resistance to the targeted medicine, Tarceva.  Therefore, it is time to take out new weapons from our armory. Gwohann will start a new chemo treatment on Tuesday, June 23, using a cocktail of three drugs, one of which Cyramza was only recently approved by the FDA and has promising effects on NSCLC.  The chemo will be administered every two weeks, and our oncologist expects that Gwohann will tolerate the side effects well and he can continue to work to maintain a sense of normalcy.

The initial disappointment and apprehension that we experienced when we first knew about the setback has passed, and we are ready to engage in the new battle with hew hope and determination.  We feel very fortunate that we live in a country where we have access to the newest medicine and technology.  Special thanks to those of you who work in biotech and research.  Your work saves lives!

Battling cancer takes a community, and we thank you for being our community.  We are greatly encouraged by your cards, phone calls, emails, meal support, visits, company for dining out or outings.  As we step into the new war zone, your support is even more important.  We thank you in advance for the care and love that you give us.

Cheers to our warrior, Gwohann!

-- Jacqueline 李佳芬